Aug 14 (Reuters) – Enorama Pharma AB: * FDA UPHOLDS REFUSE-TO-FILE DECISION ON ENORAMA PHARMA'S PMTA APPLICATIONS Source text: Further company coverage: (Gdansk Newsroom)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
BRIEF-Tanwan Expects HY Net Profit Of RMB200 MLN-RMB250 MLN
Aug 14 (Reuters) - Tanwan Inc: * EXPECTS NET PROFIT OF RMB200 MILLION-RMB250 MILLION FOR…
Social media firms urge caution on early Australia under-16 ban data
By Byron Kaye SYDNEY, Aug 14 (Reuters) - Top social media platforms urged the Australian…
Boeing's Wisk sale unlikely to kick off another divestment round
By Dan Catchpole SEATTLE, Aug 14 (Reuters) - Boeing's announcement this week that it is…
